The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 11.00 and a low estimate of 5.50. The median estimate represents a +37.69% increase from the last price of 5.81.
The current consensus among 5 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.10
Reporting Date Aug 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.